Mining the plasma proteome for cancer biomarkers
- PMID: 18385731
- DOI: 10.1038/nature06916
Mining the plasma proteome for cancer biomarkers
Abstract
Systematic searches for plasma proteins that are biological indicators, or biomarkers, for cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes and tissue proteomes (which contribute proteins to plasma) and by the extensive heterogeneity among diseases, subjects and levels of sample procurement are gradually being overcome. This is being achieved through rigorous experimental design and in-depth quantitative studies. The expected outcome is the development of panels of biomarkers that will allow early detection of cancer and prediction of the probable response to therapy. Achieving these objectives requires high-quality specimens with well-matched controls, reagent resources, and an efficient process to confirm discoveries through independent validation studies.
Similar articles
-
Proteomic profiling of human plasma for cancer biomarker discovery.Proteomics. 2017 Mar;17(6). doi: 10.1002/pmic.201600240. Epub 2016 Oct 17. Proteomics. 2017. PMID: 27550791 Review.
-
[Clinical proteomics and new biomarkers in biological fluids].Med Clin (Barc). 2008 Oct 4;131(11):426-34. doi: 10.1157/13126219. Med Clin (Barc). 2008. PMID: 18928725 Review. Spanish.
-
Optomechanical devices for deep plasma cancer proteomics.Semin Cancer Biol. 2018 Oct;52(Pt 1):26-38. doi: 10.1016/j.semcancer.2017.08.011. Epub 2017 Sep 1. Semin Cancer Biol. 2018. PMID: 28867489 Review.
-
A mouse to human search for plasma proteome changes associated with pancreatic tumor development.PLoS Med. 2008 Jun 10;5(6):e123. doi: 10.1371/journal.pmed.0050123. PLoS Med. 2008. PMID: 18547137 Free PMC article.
-
Human body-fluid proteome: quantitative profiling and computational prediction.Brief Bioinform. 2021 Jan 18;22(1):315-333. doi: 10.1093/bib/bbz160. Brief Bioinform. 2021. PMID: 32020158 Free PMC article. Review.
Cited by
-
Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.Cancer Res. 2012 Apr 15;72(8):1935-42. doi: 10.1158/0008-5472.CAN-11-3266. Epub 2012 Feb 24. Cancer Res. 2012. PMID: 22367215 Free PMC article.
-
Combined use of a solid-phase hexapeptide ligand library with liquid chromatography and two-dimensional difference gel electrophoresis for intact plasma proteomics.Int J Proteomics. 2011;2011:739615. doi: 10.1155/2011/739615. Epub 2011 Sep 8. Int J Proteomics. 2011. PMID: 22389768 Free PMC article.
-
Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.Mol Cell Proteomics. 2010 Jun;9(6):1271-80. doi: 10.1074/mcp.M900419-MCP200. Epub 2010 Feb 16. Mol Cell Proteomics. 2010. PMID: 20164060 Free PMC article.
-
Proteomics technologies for cancer liquid biopsies.Mol Cancer. 2022 Feb 15;21(1):53. doi: 10.1186/s12943-022-01526-8. Mol Cancer. 2022. PMID: 35168611 Free PMC article. Review.
-
Postmenopausal estrogen and progestin effects on the serum proteome.Genome Med. 2009 Dec 24;1(12):121. doi: 10.1186/gm121. Genome Med. 2009. PMID: 20034393 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources